Imatinib-d4

Imatinib-d4 is a deuterium substitute of Imatinib. Imatinib is an orally bioavailable tyrosine kinase inhibitor that selectively inhibits BCR/ABL， v-Abl， PDGFR， c-kit kinase activity.